Pamela A. Christopherson

Versiti Blood Center of Wisconsin

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Robert R. Montgomery

Children's Hospital of Wisconsin

Sandra L. Haberichter

Versiti Blood Center of Wisconsin

Veronica H. Flood

Versiti Blood Center of Wisconsin

Joan Cox Gill

Medical College of Wisconsin

Kenneth D. Friedman

Versiti Blood Center of Wisconsin

Daniel B. Bellissimo

University of Pittsburgh Medical Center

Thomas C. Abshire

Versiti Blood Center of Wisconsin

Margaret V. Ragni

University of Pittsburgh

Cindy A. Leissinger

Tulane University

Amy D. Shapiro

Indiana Hemophilia and Thrombosis Center

Cooperative Institutions

Weatherford College

Medical College of Wisconsin

Versiti Blood Center of Wisconsin

Children's Hospital of Wisconsin

Queen's University

Howard Hughes Medical Institute

Washington University in St. Louis

University of North Carolina at Chapel Hill

National Institutes of Health

Pfizer (United States)

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

HTRS2023.P1.6 Characterization and expression of atypical type 2B variants in the Zimmerman Program

Research and Practice in Thrombosis and Haemostasis (2023)

Pamela A. Christopherson Veronica H. Flood Sandra L. Haberichter Tricia L. Slobodianuk Patricia A. Morateck

Characterization

Expression (computer science)

10.1016/j.rpth.2023.100225

Cite

Citations (0)

Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type

Blood (2022)

Brooke Sadler Pamela A. Christopherson Crystal L. Perry Daniel B. Bellissimo Sandra L. Haberichter

Breakpoint

Pseudogene

10.1182/blood-2022-163383

Cite

Citations (0)

Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival

Blood (2006)

Sandra L. Haberichter Michael Balistreri Pamela A. Christopherson Patricia A. Morateck Stefana Gavazova

von Willebrand Disease

Protein precursor

10.1182/blood-2006-04-015065

Cite

Citations (215)

Expression of Sequence Variants Identified in Type 1 VWD Subjects in the Zimmerman Program Study Reveals Defects in VWF Secretion and Multimerization

Blood (2016)

Azza Abdelaal David Jakab Pamela A. Christopherson Robert R. Montgomery Sandra L. Haberichter

von Willebrand Disease

HEK 293 cells

Agarose gel electrophoresis

Sanger sequencing

10.1182/blood.v128.22.1398.1398

Cite

Citations (0)

Domain Distribution of Type 1 VWD Sequence Variants and Impact on Clinical and Laboratory Phenotype in the Zimmerman Program

Blood (2015)

Pamela A. Christopherson Veronica H. Flood Sandra L. Haberichter Daniel B. Bellissimo Kenneth D. Friedman

von Willebrand Disease

10.1182/blood.v126.23.758.758

Cite

Citations (0)

Quantitative Measurement of VWF Binding to the Platelet Integrin αIIbβ3 - Abnormalities Identified in Individuals with VWD

Blood (2015)

Robert R. Montgomery Veronica H. Flood Jieqing Zhu Pamela A. Christopherson Peter J. Newman

10.1182/blood.v126.23.1107.1107

Cite

Citations (0)

A Novel VWF A3 Domain Mutation with Absent Binding to Type I and Type III Collagen.

Blood (2009)

Veronica H. Flood Carol A. Lederman J.S. WREN Pamela A. Christopherson Kenneth D. Friedman

von Willebrand Disease

Ristocetin

10.1182/blood.v114.22.541.541

Cite

Citations (0)

Fourteen Percent of Healthy African Americans Participating In the Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB VWD) Are Heterozygous for the VWF Gene Mutation H817Q Associated with Type 2N Von Willebrand Disease

Blood (2010)

Kenneth D. Friedman Daniel B. Bellissimo Pamela A. Christopherson Veronica H. Flood Joan Cox Gill

von Willebrand Disease

Compound heterozygosity

Heterozygote advantage

Ristocetin

10.1182/blood.v116.21.239.239

Cite

Citations (0)

Bleeding Scores in Von Willebrand Disease (VWD) Re-Visited: Analysis of the TS Zimmerman Program for the Molecular and Clinical Biology of VWD

Blood (2008)

Joan Cox Gill Pamela A. Christopherson Veronica H. Flood Kenneth D. Friedman Robert R. Montgomery

von Willebrand Disease

10.1182/blood.v112.11.425.425

Cite

Citations (8)

Type 2M von Willebrand Disease: F606I and I662F Mutations in the Glycoprotein Ib Binding Domain Selectively Impair Ristocetin- but not Botrocetin-Mediated Binding of von Willebrand Factor to Platelets

Blood (1998)

Cheryl A. Hillery David J. Mancuso J. Evan Sadler Jay W. Ponder Mary A. Jozwiak

Ristocetin

von Willebrand Disease

Glycoprotein Ib

10.1182/blood.v91.5.1572.1572_1572_1581

Cite

Citations (4)